Literature DB >> 4299774

Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.

Z Janda, E Adam, V Vonka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4299774

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  11 in total

1.  THE USE OF THE COMPLEMENT FIXATION TEST FOR TYPING OF POLIOMYELITIC VIRUSES.

Authors:  H ZAVADOVA; D REZACOVA
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1964

2.  STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).

Authors:  V VONKA; M TARABCAK; Z JANDA
Journal:  Arch Gesamte Virusforsch       Date:  1964

3.  THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.

Authors:  V VONKA; Z JANDA; J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1964-06-17

4.  PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. 3. A SMALL SCALE TRIAL WITH USOL-D BAC VIRUS IN A CLOSED CHILD COMMUNITY.

Authors:  V VONKA; Z JANDA; J SIMON; E ADAM; H ZAVADOVA; M STAREK
Journal:  Arch Gesamte Virusforsch       Date:  1965

5.  PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.

Authors:  J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies.

Authors:  A FLACK; K HUMMELER; A D HUNT; G A JERVIS; H KOPROWSKI; T W NORTON; J STOKES
Journal:  J Am Med Assoc       Date:  1956-12-01

7.  Present status of attenuated live-virus poliomyelitis vaccine.

Authors:  A B SABIN
Journal:  J Am Med Assoc       Date:  1956-12-29

8.  Administration of an attenuated type I poliomyelitis virus to human subjects.

Authors:  H KOPROWSKI; G A JERVIS; T W NORTON
Journal:  Proc Soc Exp Biol Med       Date:  1954-06

9.  Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.

Authors:  J Simon; V Vonka; Z Janda
Journal:  Arch Gesamte Virusforsch       Date:  1965

10.  Infection induced by oral administration of attenuated poliovirus to persons possessing homotypic antibody.

Authors:  D M HORSTMANN; J R PAUL; J L MELNICK; J V DEUTSCH
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307
View more
  2 in total

1.  Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

2.  USOL-D bac (type 3 poliovirus) vaccine studies.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.